Eris Lifesciences Q3FY22 consolidated net profit at Rs. 100.76 crores

Eris Lifesciences Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 337.335 crores during the period ended December 31, 2021 as compared to Rs. 366.657 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 100.765 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 118.393 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 7.41 for the period ended December 31, 2021 as compared to Rs. 8.71 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 337.335 crs	₹366.657 crs	-8.00%
Net Profit	₹100.765 crs	₹118.393 crs	-14.89%
EPS	₹7.41	₹8.71	-14.93%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 337.335 crores during the period ended December 31, 2021 as compared to Rs.313.495 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.100.765 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.90.15 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.7.41 for the period ended December 31, 2021 as compared to Rs.6.63 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 337.335 crs	₹313.495 crs	7.60%
Net Profit	₹100.765 crs	₹90.15 crs	11.77%
EPS	₹7.41	₹6.63	11.76%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.1059.127 crores during the 9 Months period ended December 31, 2021 as compared to Rs.940.152 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.325.817 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.286.888 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.23.97 for the 9 Months period ended December 31, 2021 as compared to Rs.21.11 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹1059.127 crs	₹940.152 crs	12.65%
Net Profit	₹325.817 crs	₹286.888 crs	13.57%
EPS	₹23.97	₹21.11	13.55%

Shares of Eris Lifesciences Limited was last trading in BSE at Rs. 708.85 as compared to the previous close of Rs. 724.50. The total number of shares traded during the day was 7891 in over 1492 trades.

The stock hit an intraday high of Rs. 730.00 and intraday low of 706.35. The net turnover during the day was Rs. 5686131.00.

Source : Equity Bulls

Keywords

ErisLifesciences Q3FY22 9MFY22 ResultUpdate